SEC Tracker
Get the app

Jaguar Health JAGX

Jaguar Health amends stock plan

Item 8.01 Other events

Form
8-K
Filed
Importance
Routine
  1. Proposal 3 seeks 14% of shares for 2014 Plan
  2. Share reserve increased 6x to 2,273,154 shares
  3. Series R Preferred Stock Dividend paid on Oct 15
  4. Conversion ratio of 5 common shares per Series R preferred

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Jaguar Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Theriva Biologics TOVX public float $4M, Jun 30, 2025
  2. Q/C Technologies QCLS public float $4M, Jun 30, 2025
  3. Polomar Health Services PMHS public float $4M, Jun 30, 2025
  4. Enveric Biosciences ENVB public float $4M, Jun 30, 2025
  5. Healthy Extracts HYEX public float $4M, Jun 30, 2025